Back to search
FDAFDA · Food and drugs·Recall number D-0156-2026

Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30

Published November 26, 2025 · Recall initiated: October 10, 2025

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recall details

Brand
FESOTERODINE FUMARATE
Manufacturer
Alembic Pharmaceuticals Limited
Distributor
Nationwide in the USA.
UPC
0362332176304
Lot
Lot # 2405006633, Exp Date: 03/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
India

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card